Request a Quote

Category: Specimen Spotlight

petri dish of cell culture

Specimen Spotlight: ‘Matched Sets’ of Biospecimens Give Researchers Deep Insights

August 15, 2019

A disease is an abnormal condition, and to fully understand it, you need to compare abnormal biology against the normal. That’s the concept behind the matched sets of human biospecimens that we provide to researchers around the world.

Read More

Five Questions with Healthcare Data Expert Dave John

July 18, 2019

Dave John joined iSpecimen last month as vice president of product management. Dave is a life sciences data and informatics expert with extensive experience developing solutions for genomics, translational medicine, clinical trials and electronic health records. He will help shape future capabilities of the iSpecimen Marketplace. 1. You are a data expert. How does data […]

Read More

Five Questions with Jill Mullan

June 6, 2019

Learn more about our Chief Operating Officer, Jill Mullan.

Read More

‘iSpecimen Marketplace: Where Discovery Meets Efficiency’ Slide

iSpecimen and you, collaborating to improve biospecimen access for all

March 28, 2019

Since 2014, we at iSpecimen have been committed to helping drive medical breakthroughs by connecting researchers with the human biospecimens they need from the patients who have them. In addition to streamlining researchers’ work, this work has helped biobanks and healthcare organizations fulfill their missions (and generate new revenue) by putting their banked, remnant and prospectively collected specimens to work.

Read More

Beakers and labware

Archived FFPE tissue blocks: a remarkable value for many researchers

November 29, 2018

November Specimen Spotlight Some of the best values are hidden in plain sight, like Toyotas, index funds and refurbished electronics. The same is true in the biospecimen world. Let us walk you through it. We’re known by many clients for giving researchers access to millions of banked and clinical remnant samples through our online platform, […]

Read More

Laptop. Contact, and stethoscope sitting at

TB blood cultures from around the world help combat deadliest infectious disease

October 11, 2018

October Specimen Spotlight Tuberculosis killed 1.6 million people last year and 10 million people fell ill with the condition. Incidence of the world’s deadliest infectious disease varies widely by geography. There were fewer than 10 new cases per 100,000 in most high-income countries in 2017 – yet more than 500 per 100,000 in the hardest hit countries, including […]

Read More

Biospecimen procurement

Fresh blood samples from clinic to out-of-state lab. Every day, in a two-hour window.

September 14, 2018

September Specimen Spotlight There are two ways for research organizations to procure human biospecimens, broadly speaking: Order them from existing inventories. Have them collected explicitly for the task at hand. We offer both. Although our iSpecimen Marketplace is optimized for procurement from existing inventories around the world, we often arrange prospective custom collection of new biospecimens […]

Read More

iSpecimen Provides Custom Collections for Liquid Biopsy Innovator

August 2, 2018

August Specimen Spotlight Most any cancer is curable if diagnosed at its very onset. Unfortunately, that’s difficult to impossible –  for now, anyway. Medicine is making great strides in earlier detection, however, as illustrated in the quest for “liquid biopsies.” These emerging diagnostic tools detect biomarkers in a blood sample rather than through a traditional […]

Read More

Tumor Tissue Samples and Detailed Data for Ovarian Cancer Research

June 7, 2018

June Specimen Spotlight Approximately 22,000 American women this year will receive a diagnosis of ovarian cancer, the fifth-ranked fatal cancer among women. Among the conditions related to ovarian cancer are mutations of: The tumor-suppressing TP53 gene (mutations are seen in nearly half of ovarian cancer tumors). And the KRAS oncogene. Scientists are aggressively seeking treatments and […]

Read More

tissue blocks for finding new breast cancer therapies

Cancer Tissue Blocks for Triple Negative Breast Cancer Research

May 10, 2018

May Specimen Spotlight “Triple negative” is a less common category of breast cancer that is more challenging to treat, often requiring surgery, chemotherapy and radiation. The name signifies that the cancer is not fueled, as the majority of breast cancers are, by estrogen, progesterone or the HER-2 protein. These other cancer types can often be […]

Read More

Previous   |